JP2022500437A5 - - Google Patents
Info
- Publication number
- JP2022500437A5 JP2022500437A5 JP2021514112A JP2021514112A JP2022500437A5 JP 2022500437 A5 JP2022500437 A5 JP 2022500437A5 JP 2021514112 A JP2021514112 A JP 2021514112A JP 2021514112 A JP2021514112 A JP 2021514112A JP 2022500437 A5 JP2022500437 A5 JP 2022500437A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- hyp
- lys
- virus
- containing compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2018105703 | 2018-09-14 | ||
| CNPCT/CN2018/105703 | 2018-09-14 | ||
| CNPCT/CN2018/119072 | 2018-12-04 | ||
| CN2018119072 | 2018-12-04 | ||
| PCT/CN2019/105832 WO2020052677A1 (en) | 2018-09-14 | 2019-09-14 | New conjugates of montelukast and peptides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022500437A JP2022500437A (ja) | 2022-01-04 |
| JP2022500437A5 true JP2022500437A5 (enExample) | 2022-09-21 |
| JP7759693B2 JP7759693B2 (ja) | 2025-10-24 |
Family
ID=69777394
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021514112A Active JP7759693B2 (ja) | 2018-09-14 | 2019-09-14 | モンテルカストおよびペプチドの新規接合体 |
Country Status (27)
| Country | Link |
|---|---|
| US (2) | US11680082B2 (enExample) |
| EP (2) | EP3678705B1 (enExample) |
| JP (1) | JP7759693B2 (enExample) |
| KR (1) | KR102946621B1 (enExample) |
| CN (2) | CN111601618A (enExample) |
| AU (1) | AU2019338582B2 (enExample) |
| BR (1) | BR112021004823A2 (enExample) |
| CA (1) | CA3112420A1 (enExample) |
| DK (1) | DK3678705T5 (enExample) |
| ES (1) | ES2956509T3 (enExample) |
| FI (1) | FI3678705T3 (enExample) |
| HR (1) | HRP20230946T1 (enExample) |
| HU (1) | HUE062848T2 (enExample) |
| IL (1) | IL281426A (enExample) |
| LT (1) | LT3678705T (enExample) |
| MX (1) | MX2021002657A (enExample) |
| MY (1) | MY205435A (enExample) |
| PL (1) | PL3678705T3 (enExample) |
| PT (1) | PT3678705T (enExample) |
| RS (1) | RS64436B1 (enExample) |
| SA (1) | SA521421448B1 (enExample) |
| SG (1) | SG11202102119RA (enExample) |
| SI (1) | SI3678705T1 (enExample) |
| SM (1) | SMT202300210T1 (enExample) |
| TW (1) | TWI875712B (enExample) |
| WO (1) | WO2020052677A1 (enExample) |
| ZA (1) | ZA202101398B (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115300508A (zh) * | 2017-07-05 | 2022-11-08 | 艾缇亚(上海)制药有限公司 | 包含孟鲁司特与贻贝粘附蛋白的组合的局部制剂 |
| CN114375298A (zh) * | 2019-09-14 | 2022-04-19 | 江阴贝瑞森制药有限公司 | 新肽 |
| AU2020396109A1 (en) * | 2019-12-02 | 2022-07-07 | Enlitisa (Shanghai) Pharmaceutical Co., Ltd. | Peptides and their use in the treatment of inflammation |
| EP4132503B1 (en) * | 2020-04-10 | 2026-04-22 | University of Georgia Research Foundation, Inc. | Probenecid for use in the treatment of sars-co-v2 infections |
| US11116737B1 (en) | 2020-04-10 | 2021-09-14 | University Of Georgia Research Foundation, Inc. | Methods of using probenecid for treatment of coronavirus infections |
| KR102596264B1 (ko) * | 2020-11-30 | 2023-11-01 | 주식회사 바이오빛 | 기능성 펩티드가 결합된 생체적합 폴리펩티드를 포함하는 염증 질환의 억제용 조성물 |
| WO2022193185A1 (en) * | 2021-03-17 | 2022-09-22 | Jiangyin Usun Pharmaceutical Co., Ltd. | New conjugates |
| WO2022193186A1 (en) * | 2021-03-17 | 2022-09-22 | Jiangyin Usun Pharmaceutical Co., Ltd. | New diagnostic and therapeutic agents |
| WO2023225107A1 (en) * | 2022-05-17 | 2023-11-23 | Emory University | Diroximel fumarate, inhalation administration methods, pharmaceutical uses and compositions |
| WO2024169972A1 (en) * | 2023-02-13 | 2024-08-22 | Enlitisa (Shanghai) Pharmaceutical Co., Ltd. | New multi-functional oligopeptides |
| WO2024260465A1 (en) * | 2023-06-22 | 2024-12-26 | Enlitisa (Shanghai) Pharmaceutical Co., Ltd. | New multi-functional oligopeptides |
| WO2025087269A1 (en) * | 2023-10-23 | 2025-05-01 | Enlitisa (Shanghai) Pharmaceutical Co., Ltd. | New short-chain peptides and derivatives thereof |
| KR20250075990A (ko) * | 2023-11-22 | 2025-05-29 | 한도숙 | 상처 치료 또는 피부 주름형성 억제용 조성물 |
| TW202547549A (zh) | 2024-03-20 | 2025-12-16 | 大陸商安利提沙（上海）製藥有限公司 | 源自血管活性腸肽的肽的新用途 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6716452B1 (en) | 2000-08-22 | 2004-04-06 | New River Pharmaceuticals Inc. | Active agent delivery systems and methods for protecting and administering active agents |
| US6669951B2 (en) | 1999-08-24 | 2003-12-30 | Cellgate, Inc. | Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| WO2003020200A2 (en) * | 2000-11-16 | 2003-03-13 | New River Pharmaceuticals Inc. | A novel pharmaceutical compound and methods of making and using same |
| EP2316468A1 (en) | 2002-02-22 | 2011-05-04 | Shire LLC | Delivery system and methods for protecting and administering dextroamphetamine |
| EP1521763A2 (en) | 2002-07-08 | 2005-04-13 | Pliva - Istrazivacki Institut d.o.o. | Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| US20050107612A1 (en) | 2002-12-30 | 2005-05-19 | Dr. Reddy's Laboratories Limited | Process for preparation of montelukast and its salts |
| AU2004229501B2 (en) * | 2003-04-11 | 2011-08-18 | Medimmune, Llc | Recombinant IL-9 antibodies and uses thereof |
| EP1617805A4 (en) * | 2003-04-11 | 2012-07-04 | Medimmune Llc | METHODS FOR PREVENTING OR TREATING RESPIRATORY CONDITIONS |
| US8173840B2 (en) | 2003-07-29 | 2012-05-08 | Signature R&D Holdings, Llc | Compounds with high therapeutic index |
| AU2004289174B2 (en) | 2003-07-29 | 2011-05-19 | Signature R&D Holdings, Lcc | Amino acid prodrugs |
| ES2337915T3 (es) * | 2004-10-27 | 2010-04-30 | Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. | Conjugados con adtividad antiinflamatoria. |
| TW200740441A (en) * | 2005-06-17 | 2007-11-01 | Combinatorx Inc | Methods and reagents for the treatment of inflammatory disorders |
| JP5820378B2 (ja) | 2009-09-09 | 2015-11-24 | ファーマイン コーポレーションＰｈａｒｍａｉｎ Ｃｏｒｐｏｒａｔｉｏｎ | 治療剤の送達のための陰イオンコア組成物およびその製造ならびに使用方法 |
| CN102068432A (zh) | 2011-01-11 | 2011-05-25 | 李仲昆 | 一种由他定类和白三烯拮抗剂组成的外用复方组合物 |
| WO2012112690A2 (en) * | 2011-02-16 | 2012-08-23 | Fabius Biotechnology | Targeting of therapeutic drugs and diagnostic agents employing collagen binding domains |
| CN111012914A (zh) | 2012-01-18 | 2020-04-17 | 苏州泰飞尔医药有限公司 | 治疗肺部疾病的高穿透力前药组合物和医药组合物 |
| CA2901413A1 (en) * | 2013-03-13 | 2014-10-09 | Bruce Chandler May | Use of levocetirizine and montelukast in the treatment of vasculitis |
| US20160060328A1 (en) * | 2013-10-25 | 2016-03-03 | Lpath, Inc. | Compositions and methods for binding cysteinyl leukotrienes (cyslts) for treatment of disease |
| JP2017526728A (ja) * | 2014-09-15 | 2017-09-14 | インフラマトリー・レスポンス・リサーチ・インコーポレイテッド | 炎症介在性状態の治療におけるレボセチリジン及びモンテルカスト |
| MX2018000333A (es) * | 2015-07-20 | 2018-05-22 | Bengt I Samuelsson Institute Of Life Science Res | Producto de la proteina adhesiva de mejillon y las aplicaciones de este en la supresion de inflamaciones de la piel. |
| EP3625245A4 (en) | 2017-05-24 | 2020-12-16 | Transfert Plus, S.E.C. | PEPTIDIC COMPOUNDS, CONJUGATE COMPOUNDS AND THEIR USES IN THE TREATMENT OF INFLAMMATORY DISEASES |
| EP3648785A4 (en) * | 2017-07-05 | 2021-05-05 | Jiangyin Usun Pharmaceutical Co., Ltd. | ANTI-INFLAMMATORY USE OF PEPTIDE |
| CN115300508A (zh) | 2017-07-05 | 2022-11-08 | 艾缇亚(上海)制药有限公司 | 包含孟鲁司特与贻贝粘附蛋白的组合的局部制剂 |
-
2019
- 2019-09-14 MY MYPI2021001220A patent/MY205435A/en unknown
- 2019-09-14 JP JP2021514112A patent/JP7759693B2/ja active Active
- 2019-09-14 ES ES19856467T patent/ES2956509T3/es active Active
- 2019-09-14 SM SM20230210T patent/SMT202300210T1/it unknown
- 2019-09-14 DK DK19856467.6T patent/DK3678705T5/da active
- 2019-09-14 SI SI201930561T patent/SI3678705T1/sl unknown
- 2019-09-14 PL PL19856467.6T patent/PL3678705T3/pl unknown
- 2019-09-14 SG SG11202102119RA patent/SG11202102119RA/en unknown
- 2019-09-14 KR KR1020217010829A patent/KR102946621B1/ko active Active
- 2019-09-14 EP EP19856467.6A patent/EP3678705B1/en active Active
- 2019-09-14 CN CN201980004399.1A patent/CN111601618A/zh active Pending
- 2019-09-14 FI FIEP19856467.6T patent/FI3678705T3/fi active
- 2019-09-14 HR HRP20230946TT patent/HRP20230946T1/hr unknown
- 2019-09-14 BR BR112021004823-5A patent/BR112021004823A2/pt unknown
- 2019-09-14 US US16/645,355 patent/US11680082B2/en active Active
- 2019-09-14 PT PT198564676T patent/PT3678705T/pt unknown
- 2019-09-14 HU HUE19856467A patent/HUE062848T2/hu unknown
- 2019-09-14 AU AU2019338582A patent/AU2019338582B2/en active Active
- 2019-09-14 CA CA3112420A patent/CA3112420A1/en active Pending
- 2019-09-14 MX MX2021002657A patent/MX2021002657A/es unknown
- 2019-09-14 LT LTEPPCT/CN2019/105832T patent/LT3678705T/lt unknown
- 2019-09-14 RS RS20230654A patent/RS64436B1/sr unknown
- 2019-09-14 CN CN202310240501.6A patent/CN116785447B/zh active Active
- 2019-09-14 EP EP23176152.9A patent/EP4253404A3/en active Pending
- 2019-09-14 WO PCT/CN2019/105832 patent/WO2020052677A1/en not_active Ceased
- 2019-09-16 TW TW108133243A patent/TWI875712B/zh active
-
2021
- 2021-03-01 ZA ZA2021/01398A patent/ZA202101398B/en unknown
- 2021-03-11 SA SA521421448A patent/SA521421448B1/ar unknown
- 2021-03-11 IL IL281426A patent/IL281426A/en unknown
-
2023
- 2023-05-12 US US18/316,496 patent/US20230348536A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022500437A5 (enExample) | ||
| FI3678705T3 (fi) | Montelukastin ja peptidien konjugaatteja | |
| JP2026000993A (ja) | 新ペプチド | |
| JP2021525242A5 (enExample) | ||
| JP2023503380A5 (enExample) | ||
| CN113272298B (zh) | 用于治疗呼吸系统疾病的化合物和组合物 | |
| JP2026067913A (ja) | 新規なペプチドと多糖類とのコンジュゲート | |
| JP2026506026A (ja) | 新規多機能オリゴペプチド | |
| WO2023169557A1 (zh) | 一种次黄碱衍化合物在制备治疗肺纤维化药物中的应用 | |
| RU2021105972A (ru) | Новые конъюгаты монтелукаста и пептидов | |
| JP2024506291A5 (enExample) | ||
| RU2782532C2 (ru) | Новые составы 2-(имидазол-4-ил)-этанамида пентандиовой-1,5 кислоты для лечения и профилактики вирусных заболеваний | |
| RU2791902C2 (ru) | Новые составы 2-(имидазол-4-ил)-этанамида пентандиовой-1,5 кислоты для лечения и профилактики вирусных заболеваний | |
| WO2026077292A1 (zh) | 一种天然衍生物在制备治疗非酒精性脂肪性肝病和/或肝纤维化药物中的应用 | |
| MD3678705T2 (ro) | Conjugați de montelukast și peptide | |
| EA038170B1 (ru) | Составы 2-(имидазол-4-ил)этанамида пентандиовой-1,5 кислоты для лечения и профилактики вирусных заболеваний | |
| JP2003502441A (ja) | サーファクタントタンパク質ｃエステル |